SAN FRANCISCO, January 22, 2018 /PRNewswire/ --
The global patient positioning systems market is anticipatedto reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 4.7% CAGR during the forecast period. This market is expected to witness lucrative growth during through 2025 owing
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
According to the National Cancer Institute, in 2016, there were 1,685,210 new cases of cancer diagnosed in U.S. and 14.1 million cases globally. The most common types of cancer are breast cancer, prostate cancer, and colon and rectum cancer. This steady increase in disease prevalence acts as a driver for R&D investments in the industry. Increase in innovation has resulted in improved efficiency and accuracy of these systems in cancer therapy. These products keep patients immobile yet comfortable during radiotherapy. This is anticipated to supplement industry growth.
Rising expenditure on diagnostics procedures has been a strong force driving demand in the market. According to a research published by NCBI, majority oncologists and cardiologists in U.S. and Germany prescribe diagnostics tests and choose a treatment plan only after studying test results. Thus, demand for diagnostics tests is increasing globally.
Browse full research report with TOC on "Patient Positioning Systems Market Size, Share & Trend Analysis By Product (Tables, Accessories), Application (Surgery, Diagnostics), By End Use (Hospital, Ambulatory), And Segment Forecasts, 2014 - 2025" at: https://www.grandviewresearch.com/industry-analysis/patient-positioning-systems-market
Further key findings from the study suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global patient positioning systems market on the basis of products, application, end use, and region:
Read Our Blog By Grand View Research: https://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All